Skip to main content

Table 1 Baseline clinical characteristics and differences in spirometry and IOS parameters between patients with rheumatoid arthritis with normal and those with abnormal findings in HRCT

From: Application of impulse oscillometry to detect interstitial lung disease and airway disease in adults with rheumatoid arthritis

 

Abnormal on HRCT (n = 35)

Normal on HRCT (n = 13)

p-value

Age, years

69.0 (65.0–70.0)

55.0 (44.2–60.9)

 < 0.001

Sex, female (%)

28 (80.0)

10 (76.9)

0.818

RF

234.4 (101.5–367.2)

129.5 (38.7–220.4)

0.183

RF( +) (%)

19 (54.3)

8 (61.5)

0.656

Anti-CCP

381.2 (198.6–563.7)

114.5 (6.67–222.3)

0.013

Anti-CCP( +) (%)

24 (68.6)

9 (69.2)

0.965

CRP

0.56 (0.23–0.89)

0.18 (0.10–0.25)

0.029

ESR

18.8 (13.1–24.5)

17.5 (7.68–27.4)

0.814

Spirometry

 FVC (%)

91.9 (87.3–95.7)

102.4 (95.6–110.8)

0.038

 FEV1/FVC (%)

79 (75.2–81.0)

82 (79.1–86.0)

0.024

 MMEF25/75 (%)

57.6 (48.9–66.1)

77.9 (71.9–102.5)

0.001

 RV (%)

102 (91.6–109.4)

106.0 (89.6–118.6)

0.492

IOS

 R5 (%)

150 (128.7–176.3)

110 (93.6–128.0)

0.004

 R20 (%)

132 (118.3–146.7)

116 (106.0–133.8)

0.107

 X5 < -0.12

-0.18 (-0.22–-0.15)

-0.13 (-0.15–-0.11)

0.011

 R5-R20 > 0.07

0.13 (0.06–0.18)

0.05 (0.01–0.08)

0.008

 Fres > 14.14

16.0 (14.9–21.8)

12.1 (10.1–14.2)

0.006

 AX > 0.44

1.00 (0.56–1.89)

0.40 (0.23–0.60)

0.001

DLCO (%)

66.7 (56.3–76.7)

71.3 (61.1–89.8)

0.167

  1. CCP Cyclic citrullinated peptide antibody, C-reactive protein, DLCO Diffusing capacity of the lung for carbon monoxide, ESR Erythrocyte sedimentation rate, FVC Forced vital capacity, FEV1 Forced expiratory volume in one second, HRCT High-resolution computed tomography, IOS Impulse oscillometry, MMEF Maximal mid expiratory flow curve, RF Rheumatoid factor, RV Residual volume